Article
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques.
Antimicrobial agents and chemotherapy - 1 Nov 1996
Van Rompay K K, Cherrington J M, Marthas M L, Berardi C J, Mulato A S, Spinner A, Tarara R P, Canfield D R, Telm S, Bischofberger N, Pedersen N C
Abstract excerpt
The long-term therapeutic and toxic effects of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) were evaluated in simian immunodeficiency virus (SIV)-infected newborn rhesus macaques. Four untreated SIV-infected newborn macaques developed persistently high levels of viremia, and three of the four animals had rapidly fatal disease within 3 months. In contrast, long-term PMPA treatment of four newborn macaques starting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
